Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 8 results.
User Information
Export Records
  1. 1.   Majority of CD4(+) T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule
  2. Josefsson, L.; King, M. S.; Makitalo, B.; Brannstrom, J.; Shao, W.; Maldarelli, F.; Kearney, M. F.; Hu, W. S.; Chen, J. B.; Gaines, H.; Mellors, J. W.; Albert, J.; Coffin, J. M.; Palmer, S. E.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2011, Jul; 108(27): 11199-11204.
  1. 2.   Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
  2. Palmer, S.; Malclarelli, F.; Wiegand, A.; Bernstein, B.; Hanna, G. J.; Brun, S. C.; Kempf, D. J.; Mellors, J. W.; Coffin, J. M.; King, M. S.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2008 105(10): 3879-3884.
  1. 3.   Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients
  2. Neumann, A. U.; Polis, M. A.; Rozenberg, L.; Jackson, J. O.; Reitano, K. N.; McLaughlin, M.; Koratich, C.; Dewar, R. L.; Masur, H.; Haagmans, B. L.; Kottilil, S.
  3. Aids. 2007, Sep; 21(14): 1855-1865.
  1. 4.   Relative replication fitness of a high-level 3 '-azido-3 '- deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr -> Gly) at codon 69
  2. Imamichi, T.; Berg, S. C.; Imamichi, H.; Lopez, J. C.; Metcalf, J. A.; Falloon, J.; Lane, H. C.
  3. Journal of Virology. 2000 74(23): 10958-10964.
  1. 5.   Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy
  2. Nijhuis, M.; Schuurman, R.; de Jong, D.; Erickson, J.; Gustchina, E.; Albert, J.; Schipper, P.; Gulnik, S.; Boucher, C. A. B.
  3. Aids. 1999 13(17): 2349-2359.
  1. 6.   Protease inhibitors: resistance, cross-resistance, fitness and the choice of initial and salvage therapies
  2. Erickson, J. W.; Gulnik, S. V.; Markowitz, M.
  3. Aids. 1999 13(Suppl A): S189-S204.
  1. 7.   Inhibition of Acute-, Latent-, and Chronic-Phase Human Immunodeficiency Virus Type 1 (Hiv-1) Replication By a Bistriazoloacridone Analog That Selectively Inhibits Hiv-1 Transcription
  2. Turpin, J. A.; Buckheit, R. W.; Derse, D.; Hollingshead, M.; Williamson, K.; Palamone, C.; Osterling, M. C.; Hill, S. A.; Graham, L.; Schaeffer, C. A.; Bu, M.; Huang, M. J.; Cholody, W. M.; Michejda, C. J.; Rice, W. G.
  3. Antimicrobial Agents and Chemotherapy. 1998 42(3): 487-494.
  1. 8.   Hiv Infection - How Effective Is Drug Combination Treatment
  2. Grossman, Z.; Feinberg, M.; Kuznetsov, V.; Dimitrov, D.; Paul, W.
  3. Immunology Today. 1998 19(11): 528-532.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel